Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: RemeGen Co., Ltd.

Market Cap 50.26B 58.24B 7.43B 6.41B 5.9B 5.54B 10.4B 703B 10.51B 69.72B 27.16B 344B 27.9B 27.31B 1,193B P/E Ratio 2026 *
10.1x
P/E Ratio 2027 * 41.8x
Enterprise Value 46.78B 54.21B 6.92B 5.96B 5.49B 5.16B 9.68B 654B 9.78B 64.89B 25.28B 320B 25.97B 25.42B 1,110B EV / Sales 2026 *
6.66x
EV / Sales 2027 * 9.58x
Free-Float
62.74%
Yield 2026 *
-
Yield 2027 * -
1 day-5.20%
1 week-1.23%
Current month-17.24%
1 month-23.45%
3 months-24.50%
6 months-10.35%
Current year-5.00%
1 week 66.75
Extreme 66.75
76.4
1 month 66
Extreme 66
90.7
Current year 66
Extreme 66
123.1
1 year 48.55
Extreme 48.55
126.6
3 years 10.2
Extreme 10.2
126.6
5 years 10.2
Extreme 10.2
145.5
10 years 10.2
Extreme 10.2
149.8
Manager TitleAgeSince
Chief Executive Officer 64 03/07/2008
Director of Finance/CFO 55 27/09/2023
Corporate Secretary 60 10/05/2020
Director TitleAgeSince
Director/Board Member 64 03/07/2008
Director/Board Member 71 03/07/2008
Director/Board Member 56 10/05/2020
Date Insider Type Main position Quantity % Market Cap.
03-31Other

Founder

70,000 0.0336%
03-31Other

Director

2,970 0.0014%
03-31Other

Director

23,630 0.0113%
Change 5-day change 1-year change 3-year change Capi.($)
-5.20%-1.23%+26.20%+85.87% 7.77B
-0.71%-0.29%+56.45%+107.18% 54.92B
-1.22%+2.25%+43.78%+38.45% 44.31B
-1.43%+3.47%-15.83%-20.48% 22.96B
-1.99%-3.55%-5.97%+377.60% 21.12B
-2.91%+0.27%+13.28%-36.73% 16.31B
-2.38%-3.38%+5.53%-41.88% 15.19B
-1.70%-1.68%+24.79%+172.92% 13.32B
+1.48%+9.81%+19.29% - 12.48B
+4.10%+0.10%+108.68%+226.33% 11.21B
Average -1.20%+1.78%+27.62%+101.03% 21.96B
Weighted average by Cap. -1.14%+1.18%+31.17%+93.52%

Financials

2026 *2027 *
Net sales 7.03B 8.14B 1.04B 896M 825M 774M 1.45B 98.26B 1.47B 9.75B 3.8B 48.12B 3.9B 3.82B 167B 4.73B 5.49B 700M 603M 556M 522M 979M 66.2B 990M 6.57B 2.56B 32.42B 2.63B 2.57B 112B
Net income 3.54B 4.11B 524M 452M 416M 390M 733M 49.55B 741M 4.91B 1.91B 24.26B 1.97B 1.92B 84.08B 853M 988M 126M 109M 100M 94M 176M 11.93B 178M 1.18B 461M 5.84B 473M 463M 20.24B
Net Debt -3.48B -4.03B -515M -444M -408M -383M -720M -48.66B -728M -4.83B -1.88B -23.83B -1.93B -1.89B -82.58B -4.9B -5.67B -724M -624M -575M -540M -1.01B -68.47B -1.02B -6.79B -2.65B -33.53B -2.72B -2.66B -116B
Logo RemeGen Co., Ltd.
RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
3,048
Date Price Change Volume
16/06/26 68.40 $ -5.20% 3,257,240
15/06/26 72.15 $ -3.22% 3,655,100
12/06/26 74.55 $ +7.04% 7,815,688
11/06/26 69.65 $ -0.50% 3,155,073
10/06/26 70.00 $ +1.08% 4,094,540
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
59.02CNY
Average target price
99.01CNY
Spread / Average Target
+67.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9995 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!